JohnJ.InzerilloMD

Oncology • Washington, NC

Medical Oncology Specialist at Marion L. Shepard Cancer Center

Join to view full profile

Dr. Inzerillo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Inzerillo's full profile

Already have an account?

Office
1209 Brown St
Washington, NC 27889
Phone+1 252-975-4308

Fax+1 252-946-1540

Education & Training

Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Hematology and Medical Oncology, 1990 - 1993
UPMC Medical Education (Harrisburg)Residency, Internal Medicine, 1987 - 1990
University of C.I.F.A.S School of MedicineClass of 1986

Certifications & Licensure

NC State Medical License 1993 - 2025
PA State Medical License 1990 - 1996
NJ State Medical License 1992 - 1995
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology

Clinical Trials

Registry of Older Patients With Cancer Start of enrollment: 2009 Sep 01
Recruiting
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2013 Mar 07
Completed
Phase 2
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

34 citations
A Community-Based Multicenter Trial of Pharmacokinetically Guided 5-Fluorouracil Dosing for Personalized Colorectal Cancer Therapy
Jai N. Patel, Bert H. O'Neil, Allison M. Deal, Joseph G. Ibrahim, Gary Bradley Sherrill
The Oncologist. 2014-09-01
1 citations
Sipuleucel-T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database
Melissa Y.Y. Moey, Rahim Jiwani, Kotaro Takeda, Karyn Prenshaw, R. Wayne Kreeger
ESC Heart Failure. 2021-05-02
38 citations
The Toxicity of Daily Inhaled Amphotericin B
Jeff Gryn, Jack Goldberg, Elizabeth Johnson, Jamie Siegel, John Inzerillo
American Journal of Clinical Oncology. 1993-02-01

Professional Memberships

American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Member